Polish new drugs advertising ordinance is unrealistic, says pharma industry
This article was originally published in RAJ Devices
Executive Summary
The Polish pharmaceutical industry has criticised the new health ministry's draft Ordinance on the Advertising of Medicinal Products, claiming that - if implemented - it will restrict the industry’s freedom to carry out commercial activities. The initial aim of the draft is to transpose the updated Human Medicines Directive (2001/83/EC) into the Polish legislative system, but with the restrictions it puts forward – e.g. regarding contacts between healthcare professionals and medical sales representatives –the industry regards it as unworkable.